{"id":"ceftizoxime","rwe":[{"pmid":"41599752","year":"2026","title":"Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41571074","year":"2026","title":"EPS restructuring-linked fate of ceftizoxime in nitrifying sludge: degradation pathways, microbial adaptation and toxicity reduction.","finding":"","journal":"Environmental research","studyType":"Clinical Study"},{"pmid":"41333773","year":"2025","title":"Psittacosis chlamydia pneumonia complicated with organizing pneumonia: a case report and literature review.","finding":"","journal":"Frontiers in medicine","studyType":"Clinical Study"},{"pmid":"41259247","year":"2025","title":"Compatibility and stability of seven selected cephalosporin antibiotics during extended infusion.","finding":"","journal":"Science progress","studyType":"Clinical Study"},{"pmid":"41079651","year":"2025","title":"Macrocycle formation-mediated augmentation in reactive oxygen species production.","finding":"","journal":"Chemical science","studyType":"Clinical Study"}],"tags":[{"label":"Cephalosporin Antibacterial","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"J01DD07","category":"atc"},{"label":"Off-Patent","category":"patent"},{"label":"Generic Available","category":"availability"},{"label":"Mature","category":"status"},{"label":"Acute gonococcal cervicitis","category":"indication"},{"label":"Acute gonococcal endometritis","category":"indication"},{"label":"Acute gonococcal urethritis","category":"indication"},{"label":"Bacterial infection due to Klebsiella pneumoniae","category":"indication"},{"label":"Bacterial infection due to Serratia","category":"indication"},{"label":"Bacterial peritonitis","category":"indication"},{"label":"Approved 1980s","category":"decade"},{"label":"Anti-Bacterial Agents","category":"pharmacology"},{"label":"Anti-Infective Agents","category":"pharmacology"}],"phase":"marketed","safety":{"commonSideEffects":[{"effect":"Rash","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Fever","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Transient elevation in AST (SGOT)","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Transient elevation in ALT (SGPT)","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Transient elevation in alkaline phosphatase","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Transient eosinophilia","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Thrombocytosis","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Positive Coombs test","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site burning","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site cellulitis","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site phlebitis","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site pain","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site induration","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site tenderness","drugRate":"1%","severity":"common","organSystem":""},{"effect":"Injection site paresthesia","drugRate":"1%","severity":"common","organSystem":""}],"contraindications":["Blood coagulation disorder","Factor II deficiency","Kidney disease","Pseudomembranous enterocolitis"],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"0.5%","severity":"serious"},{"effect":"Hemolytic anemia with fatal outcome","drugRate":"0.5%","severity":"serious"},{"effect":"Stevens-Johnson syndrome","drugRate":"0.5%","severity":"serious"},{"effect":"Toxic epidermal necrolysis","drugRate":"0.5%","severity":"serious"},{"effect":"Erythema multiforme","drugRate":"0.5%","severity":"serious"},{"effect":"Aplastic anemia","drugRate":"0.5%","severity":"serious"},{"effect":"Pancytopenia","drugRate":"0.5%","severity":"serious"},{"effect":"Agranulocytosis","drugRate":"0.5%","severity":"serious"},{"effect":"Pseudomembranous colitis","drugRate":"0.5%","severity":"serious"},{"effect":"Seizures","drugRate":"0.5%","severity":"serious"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=CEFTIZOXIME","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:15:56.512981+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:16:01.846642+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CEFTIZOXIME","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:16:02.177275+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Bacterial penicillin-binding protein inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:16:03.213262+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201019/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:16:02.875103+00:00"}},"allNames":"epocelin","offLabel":[],"synonyms":["ceftizoxime sodium","ceftizoxime","ceftisomin","epocelin"],"timeline":[{"date":"1983-09-15","type":"positive","source":"DrugCentral","milestone":"FDA approval"},{"date":"1993-03-19","type":"positive","source":"FDA Orange Book","milestone":"Cefizox approved — EQ 10GM BASE/VIAL"},{"date":"1994-03-31","type":"neutral","source":"FDA Orange Book","milestone":"Generic entry — 1 manufacturer approved"}],"aiSummary":"Epocelin (CEFTIZOXIME) is a cephalosporin antibacterial drug, originally developed by Hoffmann-La Roche and currently owned by a generic manufacturer. It is a small molecule modality that was FDA approved in 1983 for various bacterial infections, including gonococcal infections and urinary tract infections. Epocelin is off-patent and has a generic manufacturer. Its half-life is 1.5 hours, but it has 0% bioavailability. It is used to treat a range of bacterial infections.","approvals":[{"date":"1983-09-15","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Epocelin","ecosystem":[{"indication":"Acute gonococcal cervicitis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Acute gonococcal endometritis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"cefotetan","slug":"cefotetan","company":""},{"name":"cefoxitin","slug":"cefoxitin","company":""}],"globalPrevalence":null},{"indication":"Acute gonococcal urethritis","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amphotericin B","slug":"amphotericin-b","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azithromycin","slug":"azithromycin","company":""}],"globalPrevalence":null},{"indication":"Bacterial infection due to Klebsiella pneumoniae","otherDrugs":[{"name":"alatrofloxacin","slug":"alatrofloxacin","company":"Pfizer"},{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"}],"globalPrevalence":null},{"indication":"Bacterial infection due to Serratia","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"},{"name":"cefotaxime","slug":"cefotaxime","company":"Sanofi Aventis Us"}],"globalPrevalence":null},{"indication":"Bacterial peritonitis","otherDrugs":[{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"aztreonam","slug":"aztreonam","company":"Bristol Myers Squibb"},{"name":"cefepime","slug":"cefepime","company":"Hospira Inc"},{"name":"ceftolozane","slug":"ceftolozane","company":"Cubist Pharms"}],"globalPrevalence":null},{"indication":"Bacterial septicemia","otherDrugs":[{"name":"Polymyxin B","slug":"polymyxin-b","company":"Monarch Pharms"},{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"azlocillin","slug":"azlocillin","company":"Bayer Pharmaceuticals Corp"}],"globalPrevalence":null},{"indication":"Bacterial urinary infection","otherDrugs":[{"name":"amikacin","slug":"amikacin","company":"Apothecon"},{"name":"amoxicillin","slug":"amoxicillin","company":"Apothecon"},{"name":"ampicillin","slug":"ampicillin","company":"Wyeth Ayerst"},{"name":"avibactam","slug":"avibactam","company":"Cerexa Inc"}],"globalPrevalence":null}],"mechanism":{"novelty":"Follow-on","modality":"Small Molecule","drugClass":"Cephalosporin Antibacterial","explanation":"","oneSentence":"","technicalDetail":"Epocelin exerts its antibacterial effect by inhibiting the action of penicillin-binding proteins (PBPs), which are essential for bacterial cell wall synthesis. This results in the disruption of the bacterial cell wall, ultimately leading to cell lysis and death."},"commercial":{"launchDate":"1983","_launchSource":"DrugCentral (FDA 1983-09-15, )"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/563","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=CEFTIZOXIME","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CEFTIZOXIME","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files","fields":["patents","exclusivity","genericManufacturers"],"source":"FDA Orange Book"}],"_enrichedAt":"2026-03-30T09:29:05.782291","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:16:04.547995+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cefotaxime","drugSlug":"cefotaxime","fdaApproval":"1981-03-11","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ceftazidime","drugSlug":"ceftazidime","fdaApproval":"1985-07-19","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ceftriaxone","drugSlug":"ceftriaxone","fdaApproval":"1984-12-21","genericCount":26,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cefmenoxime","drugSlug":"cefmenoxime","fdaApproval":"1987-12-30","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"latamoxef","drugSlug":"latamoxef","fdaApproval":"","relationship":"same-class"},{"drugName":"cefixime","drugSlug":"cefixime","fdaApproval":"1989-04-28","patentExpiry":"Dec 14, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"cefpiramide","drugSlug":"cefpiramide","fdaApproval":"1989-01-31","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"cefoperazone","drugSlug":"cefoperazone","fdaApproval":"1982-11-18","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cefpodoxime proxetil","drugSlug":"cefpodoxime-proxetil","fdaApproval":"1992-08-07","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ceftibuten","drugSlug":"ceftibuten","fdaApproval":"1995-12-20","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"cefdinir","drugSlug":"cefdinir","fdaApproval":"1997-12-04","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"cefditoren pivoxil","drugSlug":"cefditoren-pivoxil","fdaApproval":"2001-08-29","patentStatus":"Unknown","relationship":"same-class"}],"genericName":"ceftizoxime","indications":{"approved":[{"name":"Acute gonococcal cervicitis","source":"DrugCentral","snomedId":20943002,"regulator":"FDA"},{"name":"Acute gonococcal endometritis","source":"DrugCentral","snomedId":65295003,"regulator":"FDA"},{"name":"Acute gonococcal urethritis","source":"DrugCentral","snomedId":29864006,"regulator":"FDA"},{"name":"Bacterial infection due to Klebsiella pneumoniae","source":"DrugCentral","snomedId":186435004,"regulator":"FDA"},{"name":"Bacterial infection due to Serratia","source":"DrugCentral","snomedId":71120004,"regulator":"FDA"},{"name":"Bacterial peritonitis","source":"DrugCentral","snomedId":197171003,"regulator":"FDA"},{"name":"Bacterial septicemia","source":"DrugCentral","snomedId":10001005,"regulator":"FDA"},{"name":"Bacterial urinary infection","source":"DrugCentral","snomedId":312124009,"regulator":"FDA"},{"name":"Bacteroides Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Bacteroides Osteomyelitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Bacteroides Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Bacteroides Pneumonia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"E. Coli Pelvic Inflammatory Disease","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"E. Coli Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Enterobacter Pneumonia","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Escherichia coli urinary tract infection","source":"DrugCentral","snomedId":301011002,"regulator":"FDA"},{"name":"Gonorrhea","source":"DrugCentral","snomedId":15628003,"regulator":"FDA"},{"name":"Gonorrhea of rectum","source":"DrugCentral","snomedId":42746002,"regulator":"FDA"},{"name":"H. Influenzae Meningitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Haemophilus influenzae pneumonia","source":"DrugCentral","snomedId":70036007,"regulator":"FDA"},{"name":"Infection due to Enterobacteriaceae","source":"DrugCentral","snomedId":128945009,"regulator":"FDA"},{"name":"Infection due to Escherichia coli","source":"DrugCentral","snomedId":71057007,"regulator":"FDA"},{"name":"Infection due to Staphylococcus aureus","source":"DrugCentral","snomedId":406602003,"regulator":"FDA"},{"name":"Infection of bone","source":"DrugCentral","snomedId":111253001,"regulator":"FDA"},{"name":"Infection of skin AND/OR subcutaneous tissue","source":"DrugCentral","snomedId":19824006,"regulator":"FDA"},{"name":"Infectious disease of abdomen","source":"DrugCentral","snomedId":128070006,"regulator":"FDA"},{"name":"Infectious disorder of joint","source":"DrugCentral","snomedId":363162000,"regulator":"FDA"},{"name":"Klebsiella Pneumoniae Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Klebsiella cystitis","source":"DrugCentral","snomedId":60867007,"regulator":"FDA"},{"name":"Lower respiratory tract infection","source":"DrugCentral","snomedId":50417007,"regulator":"FDA"},{"name":"Meningitis","source":"DrugCentral","snomedId":7180009,"regulator":"FDA"},{"name":"Morganella Morganii Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Osteomyelitis due to Staphylococcus aureus","source":"DrugCentral","snomedId":428783003,"regulator":"FDA"},{"name":"Pelvic Inflammatory Disease with Neisseria Gonorrhea","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptococcus Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptococcus Osteomyelitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptococcus Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptostreptococcus Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptostreptococcus Osteomyelitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptostreptococcus Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Peptostreptococcus infection","source":"DrugCentral","snomedId":135341000119101,"regulator":"FDA"},{"name":"Pneumonia","source":"DrugCentral","snomedId":233604007,"regulator":"FDA"},{"name":"Pneumonia due to Escherichia coli","source":"DrugCentral","snomedId":51530003,"regulator":"FDA"},{"name":"Pneumonia due to Streptococcus","source":"DrugCentral","snomedId":34020007,"regulator":"FDA"},{"name":"Proteus Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Proteus Mirabilis Osteomyelitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Proteus pneumonia","source":"DrugCentral","snomedId":195888009,"regulator":"FDA"},{"name":"Proteus urinary tract infection","source":"DrugCentral","snomedId":301012009,"regulator":"FDA"},{"name":"Providencia Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Pseudomonas Aeruginosa Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Rhinoscleroma","source":"DrugCentral","snomedId":72409005,"regulator":"FDA"},{"name":"Sepsis due to Staphylococcus aureus","source":"DrugCentral","snomedId":448417001,"regulator":"FDA"},{"name":"Septicemia due to Bacteroides","source":"DrugCentral","snomedId":79587009,"regulator":"FDA"},{"name":"Septicemia due to Escherichia coli","source":"DrugCentral","snomedId":9323009,"regulator":"FDA"},{"name":"Septicemia due to Serratia","source":"DrugCentral","snomedId":82091000,"regulator":"FDA"},{"name":"Serratia Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Skin and Skin Structure Bacteroides Fragilis Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Skin and Skin Structure Peptococcus Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Skin and Skin Structure Proteus Infection","source":"DrugCentral","snomedId":"","regulator":"FDA","globalPrevalence":251400000,"prevalenceMethod":"ai-extracted","prevalenceSource":"Pathogens, 2024 (PMID:39452777)"},{"name":"Skin and Skin Structure Serratia Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcal pneumonia","source":"DrugCentral","snomedId":22754005,"regulator":"FDA"},{"name":"Staphylococcus Aureus Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcus Aureus Urinary Tract Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcus Epidermidis Skin and Skin Structure Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Staphylococcus Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Streptococcal Joint Infection","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Streptococcal Pelvic Inflammatory Disease","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Streptococcal Peritonitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Streptococcal meningitis","source":"DrugCentral","snomedId":4510004,"regulator":"FDA"},{"name":"Streptococcal septicemia","source":"DrugCentral","snomedId":29577008,"regulator":"FDA"},{"name":"Streptococcus Osteomyelitis","source":"DrugCentral","snomedId":"","regulator":"FDA"},{"name":"Streptococcus pyogenes infection","source":"DrugCentral","snomedId":302809008,"regulator":"FDA"},{"name":"Urinary tract infectious disease","source":"DrugCentral","snomedId":68566005,"regulator":"FDA"}],"offLabel":[{"name":"Pyrexia of unknown origin","source":"DrugCentral","drugName":"CEFTIZOXIME","evidenceCount":0,"evidenceLevel":"emerging"}],"pipeline":[]},"drugCategory":"mature","labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[{"drugId":"cefotaxime","brandName":"cefotaxime","genericName":"cefotaxime","approvalYear":"1981","relationship":"same-class"},{"drugId":"ceftazidime","brandName":"ceftazidime","genericName":"ceftazidime","approvalYear":"1985","relationship":"same-class"},{"drugId":"ceftriaxone","brandName":"ceftriaxone","genericName":"ceftriaxone","approvalYear":"1984","relationship":"same-class"},{"drugId":"cefmenoxime","brandName":"cefmenoxime","genericName":"cefmenoxime","approvalYear":"1987","relationship":"same-class"},{"drugId":"latamoxef","brandName":"latamoxef","genericName":"latamoxef","approvalYear":"","relationship":"same-class"},{"drugId":"cefixime","brandName":"cefixime","genericName":"cefixime","approvalYear":"1989","relationship":"same-class"},{"drugId":"cefpiramide","brandName":"cefpiramide","genericName":"cefpiramide","approvalYear":"1989","relationship":"same-class"},{"drugId":"cefoperazone","brandName":"cefoperazone","genericName":"cefoperazone","approvalYear":"1982","relationship":"same-class"},{"drugId":"cefpodoxime-proxetil","brandName":"cefpodoxime proxetil","genericName":"cefpodoxime proxetil","approvalYear":"1992","relationship":"same-class"},{"drugId":"ceftibuten","brandName":"ceftibuten","genericName":"ceftibuten","approvalYear":"1995","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04771884","phase":"","title":"Population Pharmacokinetics of Commonly Used Antimicrobial Agents in Children of Bacterial Meningitis With Augmented Renal Clearance","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2020-10-01","conditions":["Bacterial Meningitis","Augmented Renal Clearance"],"enrollment":300,"completionDate":"2026-03-20"},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":["Osteomyelitis"],"enrollment":11,"completionDate":"2018-11-07"},{"nctId":"NCT01347593","phase":"PHASE4","title":"Prophylactic Ceftizoxime (Cefizox) for Elective Cesarean Delivery","status":"COMPLETED","sponsor":"University of Khartoum","startDate":"2011-05","conditions":["Caesarean"],"enrollment":220,"completionDate":"2011-08"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"_patentsChecked":true,"crossReferences":{"NUI":"N0000179458","MMSL":"4386","NDDF":"002729","UNII":"C43C467DPE","VUID":"4017998","CHEBI":"CHEBI:553473","VANDF":"4017998","INN_ID":"4743","RXNORM":"2192","UMLSCUI":"C0007560","chemblId":"CHEMBL1201019","ChEMBL_ID":"CHEMBL528","KEGG_DRUG":"D00923","DRUGBANK_ID":"DB01332","PUBCHEM_CID":"6533629","SNOMEDCT_US":"372770006","IUPHAR_LIGAND_ID":"10785","SECONDARY_CAS_RN":"68401-82-1","MESH_DESCRIPTOR_UI":"D015296"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","halfLife":"1.5 hours","clearance":"2.1 mL/min/kg","bioavailability":"0%","fractionUnbound":"0.72%","volumeOfDistribution":"0.2 L/kg"},"publicationCount":974,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"J01DD07","allCodes":["J01DD07"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Jan 15","pmid":"41599752","title":"Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database.","journal":"Pharmaceuticals (Basel, Switzerland)"},{"date":"2026 Mar 1","pmid":"41571074","title":"EPS restructuring-linked fate of ceftizoxime in nitrifying sludge: degradation pathways, microbial adaptation and toxicity reduction.","journal":"Environmental research"},{"date":"2025","pmid":"41333773","title":"Psittacosis chlamydia pneumonia complicated with organizing pneumonia: a case report and literature review.","journal":"Frontiers in medicine"},{"date":"2025 Oct-Dec","pmid":"41259247","title":"Compatibility and stability of seven selected cephalosporin antibiotics during extended infusion.","journal":"Science progress"},{"date":"2025 Nov 12","pmid":"41079651","title":"Macrocycle formation-mediated augmentation in reactive oxygen species production.","journal":"Chemical science"}],"companionDiagnostics":[],"genericManufacturers":1,"_genericFilersChecked":true,"genericManufacturerList":["Astellas"],"status":"approved","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1983","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1983-09-15T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:16:04.547995+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}